Article Details

Piper Sandler sustains Overweight rating on Sutro Biopharma shares - Investing.com

Retrieved on: 2024-10-11 16:20:18

Tags for this article:

Click the tags to see associated articles and topics

Piper Sandler sustains Overweight rating on Sutro Biopharma shares - Investing.com. View article details on hiswai:

Excerpt

Sutro Biopharma has a strategic plan to file three Investigational New Drug (IND) applications over the coming three years. This includes the ...

Article found on: www.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up